Page results
-
The new artwork celebrates the pioneering researcher, teacher and neurology consultant at the National Hospital for Neurology and Neurosurgery.
-
Patients with COVID-19 will be given the cystic fibrosis drug ‘Dornase alfa’ to determine if it can help improve survival by reducing excess inflammation in the lungs in a trial at UCLH.
-
UCLH has achieved excellent results in the 2024 National Adult Inpatient Survey, with patients rating their overall care 8.4 out of 10. This gives UCLH the second highest score of London’s acute teaching hospitals.
-
Elderly patients on University College Hospital’s T10 ward enjoyed the therapeutic benefits of music, thanks to a recent residency by two musicians.
-
Neurological complications of COVID-19 can include delirium, brain inflammation, stroke and nerve damage, finds a new UCL and UCLH-led study.
-
Our Getting Ready for Transition (GReaT) to secondary school parent information session will run on Tuesday 31 January 2023.
-
UCLH will be part of a major UK research study looking at the long-term health impacts of COVID-19.
-
We’re proud that UCLH is ranked number one of all acute teaching trusts in new national league tables published today.
-
A quicker, cheaper MRI scan is just as accurate at diagnosing prostate cancer as the current 30-40 minute scan and should be rolled out to make MRI scans more accessible to men who need one, according to clinical trial results led by UCLH, UCL and the University of Birmingham.
-
Information about the Integrated Women's Service at the RLHIM patient information leaflet
File results
-
FOI2017204 Children treated for alcohol or drug related issues
-
FOI/2023/0443 - Food provision at Trust for staff and patients
-
FOI/2023/0444 - Emergency scrotal explorations (surgical procedure) for June 2022-May 2023
-
FOI/2023/0445 - Number of people (patients, staff, members of public) stabbed from 2018-2022
-
FOI/2023/0448 - Gender, transgender, non-binary guidance/ policy for staff and patients
-
FOI/2023/0449 - Endometriosis pathway
-
FOI/2023/0450 - Pain relief options (remifentanil, entonox and sterile water injections) during labour
-
FOI2017193 Risk management information
-
FOI2017189 Cost and number of tattoos removed
-
FOI2017190 Consultants undertaking private work